Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): Explanation and ElaborationDouglas G. Altman, Sheila E. Taube|PLoS Medicine|2012Cited by 1k
A Perspective on Challenges and Issues in Biomarker Development and Drug and Biomarker CodevelopmentSheila E. Taube, Steven Gutman|JNCI Journal of the National Cancer Institute|2009Cited by 127